Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-20
1992-02-25
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514215, 540578, 546118, A61K 31435, C07D47104
Patent
active
050913905
ABSTRACT:
Provided are 4,5,6,7-tetrahydro-1H-imidazo(4,5-c)-pyridine derivatives, methods for preparing them, pharmaceutical compositions containing them, and methods of using them to treat disorders of mammals mediated by AII type-2 receptors in the central nervous system.
REFERENCES:
patent: 4812462 (1989-03-01), Blankley et al.
John M. Morgan, "Angiotensin Injected into the Neostriatum After Learning Disrupts Retention Performance" Apr. 1977, pp. 87-89 Science vol. 196.
B. A. Scholkens, W. Jung, W. Rascher, R. Dietz and D Ganten, "Intracerebroventricular angiotensin II increases arterial blood pressure in rhesus monkeys by stimulation of pituitary hormones and the sympathetic nervous system", Jul. 15, 1981, pp. 469-470.
Steven Whitebread, Michele Mele, Bruno Kamber and Marc de Gasparo, "Preliminary Biochemical Characterization of Two Angiotensin II Receptor Subtypes", Aug. 1989, pp. 284-291, Biochemical and Biophysical Research Communications.
James P. Bennett, Jr. and Solomon H. Snyder, "Angiotensin II Binding to Mammalian Brain Membranes", Dec. 1976, pp. 7423-7430, The Journal Of Biological Chemistry, vol. 251, No. 23.
Chiu et al., "Identification of Angiotensin II Receptor Subtypes", Nov. 1989, pp. 196-203, Biochemical and Biophysical Research Communications, vol. 165, No. 1.
Barnes et al., "Angiotensin II inhibits the release of [.sup.3 H] acetylcholine from rat entorhinal cortex in vitro", 1989, pp. 136-143.
Costall et al., "The Effects of ACE Inhibitors Captopril and SQ29,852 in Rodent Tests of Cognition", 1989, pp. 573-579.
Usinger et al., "Indications on the Memory-Enhancing Effects of a Peptidase Inhibitor", 1988, pp. 315-324.
Arregui et al., "Angiotensin Converting Enzyme in Alzheimer's Disease Increased Activity in Caudate Nucleus and Cortical Areas", 1982, pp. 1490-1492, Journal of Neuro Chemistry.
Koller et al., "Endogenous Brain Angiotensin II Disrupts Passive Avoidance Behavior In Rats", 1979, pp. 71-75.
Unger et al., "Brain angiotensin: pathways and pharmacology", 1988, pp. 140-154.
J. F. E. Mann, "Brain Angiotensin II Receptors: Possible Physiological Implications", 1982, pp. 242-254.
James T. Fitzsimons, "Angiotensin Stimulation of the Central Nervous System", 1980, pp. 117-167, Rev. Physiol. Biochem. Pharmacol., vol. 87.
Zubenko et al., "Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme, Acetylcholinesterase, and Dopamine Metabolites in Dementia Associated with Alzheimer's Disease and Parkinson's Disease; A Correlative Study", 1986, pp. 1365-1381.
Koller et al., "Endogenous Brain Angiotensin II Disrupts Passive Avoidance Behavior In Rats", 1979, pp. 71-75.
Ardecky Robert J.
Chiu Andrew T.
Duncia John J. V.
Timmermans Petrus B. M. W. M.
Wexler Ruth R.
Dentz Bernard
E. I. Du Pont de Nemours and Company
LandOfFree
Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of CNS disorders with 4,5,6,7-tetrahydro-1H-imidazo (4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1893136